Abstract
In order to assess bioactivity profiles for small organic molecules we propose to use parallel pharmacophore-based virtual screening. Our aim is to provide a fast, reliable and scalable system that allows for rapid in silico activity profile prediction of virtual molecules. In this proof of principle study, carried out with the new structure-based pharmacophore modelling tool LigandScout and the high-performance database mining platform Catalyst, we present a model work for the application of parallel pharmacophore-based virtual screening on a set of 50 structure-based pharmacophore models built for various viral targets and 100 antiviral compounds. The latter were screened against all pharmacophore models in order to determine if their known biological targets could be correctly predicted via an enrichment of corresponding pharmacophores matching these ligands. The results demonstrate that the desired enrichment, i.e. a successful activity profiling, was achieved for approximately 90% of all input molecules. Additionally, we discuss descriptors for output validation, as well as various aspects influencing the analysis of the obtained activity profiles, and the effect of the searching mode utilized for screening. The results of the study presented here clearly indicate that pharmacophore-based parallel screening comprises a reliable in silico method to predict the potential biological activities of a compound or a compound library by screening it against a series of pharmacophore queries.
Similar content being viewed by others
References
Langer T, Krovat E-M (2003) Curr Opin Drug Discov Dev 6:370
Krovat E-M, Steindl T, Langer T (2005) Curr Comput-Aided Drug Des 1:93
Güner OF, Clement O, Kurogi Y (2005) Curr Med Chem 11:2991
Güner OF (2005) IDrugs 8:567
Langer T, Wolber G (2004) Pure Appl Chem 76:991
Schuster D, Langer T (2005) J Chem Inf Model 45:431
Sanguinetti MC, Mitcheson JS (2005) Trends Pharmacol Sci 26:119
Clement OO, Guener OF (2004) In: Testa B (ed) Proceedings of the 3rd pharmacokinetic profiling in drug research: biological, physicochemical, and computational strategies. Verlag Helvetica Chimica Acta, Zurich, pp381
Klabunde T, Evers A (2005) ChemBioChem 6:876
Norinder U (2005) QSAR Environ Res 16:1
Oloff S, Zhang S, Sukumar N, Breneman C, Tropsha A (2006) J Chem Inf Model 46:844–851
Cleves AE, Jain AN (2006) J Med Chem 49:2921
LigandScout 1.0 is available from Inte:Ligand GmbH, Vienna, Austria (http://www.inteligand.com/ligandscout)
Wolber G, Langer T (2005) J Chem Inf Model 45:160
Schuster D, Laggner C, Palusczak A, Hartmann RW, Langer T (2006) J Chem Inf Model 46:1301
Krovat E-M, Frühwirth KH, Langer T (2005) J Chem Inf Model 45:146
Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H, Shindyalov I, Bourne P (2000) Nucleic Acids Res 28:235
Zuckerman AJ, et al (2000) Principles and practice of clinical virology, 4th edn. Wiley, Chinchester New York Weinheim Brisbane Singapore Toronto
Catalyst Version 4.11 available from Accelrys Inc, San Diego, CA, USA
Derwent World Drug Index, available in Catalyst data format from Accelrys Inc, San Diego, CA, USA
De Clercq E (2004) J Clin Virol 30:115
Ren J, Nichols C, Bird L, Chamberlain P, Weaver K, et al (2001) J Mol Biol 312:795
Alymova IV, Taylor G, Portner A (2005) Curr Drug Targets Infect Disord 5:401
Hadfield AT, Diana GD, Rossmann MG (1999) Proc Natl Acad Sci USA 96:14730
Kirchmair J, Laggner C, Wolber G, Langer T (2005) J Chem Inf Model 45:422
Kirchmair J, Wolber G, Laggner C, Langer T (2006) J Chem Inf Model 46:1848
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steindl, T.M., Schuster, D., Wolber, G. et al. High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening. J Comput Aided Mol Des 20, 703–715 (2006). https://doi.org/10.1007/s10822-006-9066-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-006-9066-y